Clinical Trials Browser

Active not recruiting × telisotuzumab vedotin × Tumor-Agnostic × Clear all

NCT02099058 2025-08-14

A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors

Phase 1 Active not recruiting

Neoplasms